Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-25 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,513 | $0.9561 | 1,393,405 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-26 5:32 pm |
N/A 2035-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
680,000 | $0 | 1,393,405 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 5:32 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,792 | $1 | 1,393,405 (Direct) |
View |
| 2025-01-22 Tax Withholding |
2025-01-24 4:05 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
129,593 | $1.15 | 716,710 (Direct) |
View |
| 2024-11-24 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,787 | $1.88 | 841,303 (Direct) |
View |
| 2024-11-25 Tax Withholding |
2024-11-26 4:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
1,508 | $1.94 | 841,303 (Direct) |
View |
| 2024-08-24 Tax Withholding |
2024-08-27 4:37 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
3,295 | $0.86 | 844,598 (Direct) |
View |
| 2024-05-24 Tax Withholding |
2024-05-29 5:18 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
3,295 | $0.6 | 842,893 (Direct) |
View |
| 2024-02-24 Tax Withholding |
2024-02-27 5:13 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
10,484 | $1.13 | 846,188 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:40 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
712,500 | $0 | 856,672 (Direct) |
View |
| 2023-11-25 Tax Withholding |
2023-11-28 4:16 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
1,462 | $0.3821 | 139,172 (Direct) |
View |
| 2023-08-25 Tax Withholding |
2023-08-29 4:13 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
1,462 | $0.77 | 140,634 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:43 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
1,462 | $1.33 | 137,096 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:08 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
302,813 | $0 | 387,933 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:08 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
9,834 | $2.66 | 387,933 (Direct) |
View |
Ownership |
2022-09-19 7:24 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
0 | $0 | 419,581 (Direct) |
View |